Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$181.58
0.360.20%
À la fermeture: -
$181.58
0.000.00%
Après les heures de négociation: 4:31 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Universal Health Services Inc a un objectif de cours consensus de $203.77, basé sur les évaluations des 29 analystes. Le plus élevé est de $267 attribué par UBS le août 14, 2024, et le plus bas est de $142 attribué par Barclays le septembre 21, 2023. Les 3 dernières évaluations d'analystes ont été publiées par Cantor Fitzgerald, RBC Capital et Baird le août 26, 2025, août 19, 2025 et août 14, 2025. Avec un objectif de cours moyen de $212 entre Cantor Fitzgerald, RBC Capital et Baird, il y a une variation implicite de 16.75% upside pour Universal Health Services Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Cantor Fitzgerald
RBC Capital
Baird
Wells Fargo
JP Morgan
1calculé à partir des notes des analystes
Notes d'analystes pour Universal Health Services
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/26/2025 | 25.01% | Cantor Fitzgerald | $227 → $227 | Reiterates | Neutral → Neutral | |||
08/19/2025 | 13.45% | RBC Capital | $201 → $206 | Maintains | Sector Perform | |||
08/14/2025 | 11.8% | Baird | $243 → $203 | Maintains | Neutral | |||
08/14/2025 | 15.65% | Wells Fargo | $225 → $210 | Maintains | Overweight | |||
08/04/2025 | 7.39% | JP Morgan | $215 → $195 | Maintains | Neutral | |||
07/30/2025 | 42.64% | Barclays | $257 → $259 | Maintains | Overweight | |||
07/16/2025 | 1.88% | B of A Securities | $215 → $185 | Downgrade | Neutral → Underperform | |||
04/30/2025 | 10.7% | RBC Capital | $211 → $201 | Maintains | Sector Perform | |||
04/29/2025 | 41.54% | Barclays | $249 → $257 | Maintains | Overweight | |||
04/15/2025 | 23.36% | Baird | $274 → $224 | Downgrade | Outperform → Neutral | |||
04/09/2025 | 14.55% | Guggenheim | → $208 | Initiates | → Buy | |||
03/26/2025 | 10.14% | Morgan Stanley | → $200 | Initiates | → Equal-Weight | |||
03/10/2025 | 23.91% | Wells Fargo | $230 → $225 | Maintains | Overweight | |||
02/28/2025 | 22.81% | Stephens & Co. | $210 → $223 | Maintains | Equal-Weight | |||
02/27/2025 | 15.65% | Stephens & Co. | $210 → $210 | Reiterates | Equal-Weight → Equal-Weight | |||
02/27/2025 | 37.13% | Barclays | $271 → $249 | Maintains | Overweight | |||
12/17/2024 | 24.46% | JP Morgan | → $226 | Assumes | → Neutral | |||
11/26/2024 | 38.23% | TD Cowen | $275 → $251 | Maintains | Buy | |||
11/25/2024 | 26.67% | Wells Fargo | $285 → $230 | Maintains | Overweight | |||
11/06/2024 | 56.96% | Wells Fargo | $275 → $285 | Maintains | Overweight | |||
10/28/2024 | 51.45% | TD Cowen | $283 → $275 | Maintains | Buy | |||
10/28/2024 | 16.2% | RBC Capital | $222 → $211 | Maintains | Sector Perform | |||
10/25/2024 | 49.25% | Barclays | $256 → $271 | Maintains | Overweight | |||
10/25/2024 | 20.61% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
10/22/2024 | 51.45% | Wells Fargo | $255 → $275 | Maintains | Overweight | |||
10/16/2024 | 55.85% | TD Cowen | $220 → $283 | Upgrade | Hold → Buy | |||
10/11/2024 | — | Keybanc | — | Initiates | → Sector Weight | |||
10/04/2024 | 20.61% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
10/01/2024 | 20.61% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
09/09/2024 | 22.26% | RBC Capital | $189 → $222 | Maintains | Sector Perform | |||
09/04/2024 | 50.9% | Baird | $236 → $274 | Maintains | Outperform | |||
08/20/2024 | 20.61% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
08/19/2024 | 20.61% | Cantor Fitzgerald | $219 → $219 | Reiterates | Neutral → Neutral | |||
08/14/2024 | 47.04% | UBS | $247 → $267 | Maintains | Buy | |||
07/30/2024 | 26.12% | Goldman Sachs | $200 → $229 | Maintains | Buy | |||
07/30/2024 | 40.43% | Wells Fargo | $200 → $255 | Maintains | Overweight | |||
07/26/2024 | 21.16% | TD Cowen | $183 → $220 | Maintains | Hold | |||
07/26/2024 | 20.61% | Cantor Fitzgerald | $162 → $219 | Upgrade | Underweight → Neutral | |||
07/26/2024 | 40.98% | Barclays | $198 → $256 | Upgrade | Equal-Weight → Overweight | |||
07/25/2024 | 10.14% | Stephens & Co. | $200 → $200 | Reiterates | Equal-Weight → Equal-Weight | |||
07/25/2024 | -10.78% | Cantor Fitzgerald | $162 → $162 | Reiterates | Underweight → Underweight | |||
07/10/2024 | 9.04% | Barclays | $189 → $198 | Maintains | Equal-Weight | |||
07/10/2024 | -10.78% | Cantor Fitzgerald | $162 → $162 | Reiterates | Underweight → Underweight | |||
07/09/2024 | -10.78% | Cantor Fitzgerald | $162 → $162 | Reiterates | Underweight → Underweight | |||
07/02/2024 | -10.78% | Cantor Fitzgerald | $162 → $162 | Reiterates | Underweight → Underweight | |||
06/26/2024 | 29.97% | Baird | $198 → $236 | Upgrade | Neutral → Outperform | |||
05/30/2024 | 2.43% | JP Morgan | $182 → $186 | Maintains | Neutral | |||
05/30/2024 | 9.04% | Baird | → $198 | Initiates | → Neutral | |||
05/20/2024 | 24.46% | UBS | $189 → $226 | Upgrade | Neutral → Buy | |||
05/07/2024 | 4.09% | RBC Capital | $183 → $189 | Maintains | Sector Perform | |||
04/30/2024 | 0.78% | TD Cowen | $181 → $183 | Maintains | Hold | |||
04/26/2024 | 4.09% | Barclays | $181 → $189 | Maintains | Equal-Weight | |||
04/25/2024 | 1.88% | Stephens & Co. | $185 → $185 | Reiterates | Equal-Weight → Equal-Weight | |||
04/12/2024 | 11.8% | Deutsche Bank | $208 → $203 | Maintains | Buy | |||
04/10/2024 | -14.09% | Cantor Fitzgerald | $156 → $156 | Reiterates | Underweight → Underweight | |||
03/28/2024 | 10.14% | Wells Fargo | $195 → $200 | Maintains | Overweight | |||
03/13/2024 | 0.23% | JP Morgan | $144 → $182 | Maintains | Neutral | |||
03/12/2024 | 0.78% | RBC Capital | $161 → $183 | Maintains | Sector Perform | |||
03/06/2024 | 10.14% | Mizuho | $175 → $200 | Maintains | Buy | |||
03/06/2024 | -0.32% | Barclays | → $181 | Initiates | → Equal-Weight | |||
03/05/2024 | -14.09% | Cantor Fitzgerald | $156 → $156 | Reiterates | Underweight → Underweight | |||
03/04/2024 | 4.09% | Goldman Sachs | $170 → $189 | Maintains | Buy | |||
03/01/2024 | -0.32% | TD Cowen | $140 → $181 | Maintains | Market Perform | |||
02/29/2024 | -14.09% | Cantor Fitzgerald | $148 → $156 | Maintains | Underweight | |||
02/29/2024 | 6.29% | Citigroup | $170 → $193 | Maintains | Buy | |||
02/29/2024 | -2.52% | UBS | $152 → $177 | Maintains | Neutral | |||
01/02/2024 | -2.52% | Wells Fargo | → $177 | Upgrade | Equal-Weight → Overweight | |||
12/11/2023 | — | Goldman Sachs | — | Upgrade | Sell → Buy | |||
11/17/2023 | -20.7% | JP Morgan | $152 → $144 | Maintains | Neutral | |||
10/20/2023 | -23.45% | Wells Fargo | $153 → $139 | Maintains | Equal-Weight | |||
09/21/2023 | -21.8% | Barclays | $142 → $142 | Maintains | Equal-Weight | |||
09/14/2023 | -18.49% | Cantor Fitzgerald | → $148 | Reiterates | Underweight → Underweight | |||
07/27/2023 | 0.78% | B of A Securities | → $183 | Maintains | Buy | |||
07/27/2023 | -15.74% | Wells Fargo | → $153 | Maintains | Equal-Weight | |||
07/27/2023 | -6.93% | Credit Suisse | $163 → $169 | Maintains | Outperform | |||
07/26/2023 | -14.64% | Stephens & Co. | → $155 | Reiterates | Equal-Weight → Equal-Weight | |||
07/11/2023 | -6.38% | Mizuho | $150 → $170 | Maintains | Buy | |||
06/02/2023 | -10.23% | B of A Securities | → $163 | Assumes | Neutral → Buy | |||
05/26/2023 | — | SVB Securities | — | Upgrade | Market Perform → Outperform | |||
05/16/2023 | -23.45% | Goldman Sachs | $124 → $139 | Maintains | Sell | |||
05/16/2023 | -17.39% | Mizuho | $140 → $150 | Maintains | Buy | |||
05/08/2023 | -15.19% | TD Cowen | $138 → $154 | Maintains | Market Perform | |||
04/27/2023 | -9.13% | Citigroup | $150 → $165 | Maintains | Buy | |||
04/27/2023 | -20.15% | Stephens & Co. | $140 → $145 | Maintains | Equal-Weight | |||
04/27/2023 | -14.64% | Deutsche Bank | $145 → $155 | Maintains | Buy | |||
04/27/2023 | -16.29% | RBC Capital | $130 → $152 | Maintains | Sector Perform | |||
04/27/2023 | -10.23% | Credit Suisse | $153 → $163 | Maintains | Outperform | |||
04/25/2023 | -21.8% | Barclays | $132 → $142 | Upgrade | Underweight → Equal-Weight | |||
04/21/2023 | -21.25% | Cantor Fitzgerald | → $143 | Initiates | → Underweight | |||
04/19/2023 | -14.64% | UBS | $167 → $155 | Maintains | Neutral | |||
04/19/2023 | -26.75% | JP Morgan | → $133 | Initiates | → Neutral | |||
03/06/2023 | -20.15% | Deutsche Bank | $168 → $145 | Maintains | Buy | |||
03/06/2023 | -22.9% | Mizuho | $144 → $140 | Maintains | Buy | |||
03/06/2023 | -24% | Wells Fargo | $154 → $138 | Maintains | Equal-Weight | |||
03/03/2023 | -15.74% | Credit Suisse | $157 → $153 | Maintains | Outperform | |||
03/01/2023 | -28.41% | RBC Capital | $114 → $130 | Maintains | Sector Perform | |||
03/01/2023 | -22.9% | Stephens & Co. | $155 → $140 | Maintains | Equal-Weight | |||
03/01/2023 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
02/28/2023 | -11.88% | B of A Securities | → $160 | Maintains | Neutral | |||
02/28/2023 | -14.64% | Stephens & Co. | → $155 | Reiterates | → Equal-Weight |
FAQ
Quel est le cours indicatif de l'action Universal Health Services (UHS) ?
Le dernier objectif de prix pour Universal Health Services (NYSE:UHS) a été rapporté par Cantor Fitzgerald le août 26, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $227.00 s'attendant à ce que UHS se rise dans les 12 prochains mois (un possible changement de 25.01% upside). 31 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Universal Health Services (UHS) ?
La dernière note d'analyste pour Universal Health Services (NYSE:UHS) a été fournie par Cantor Fitzgerald, et Universal Health Services réitéré leur note neutral.
Quand a eu lieu la dernière mise à niveau pour Universal Health Services (UHS) ?
La dernière amélioration pour Universal Health Services Inc a eu lieu le octobre 16, 2024 lorsque TD Cowen a augmenté leur objectif de prix à $283. TD Cowen avait précédemment a hold pour Universal Health Services Inc.
Quand a eu lieu la dernière dégradation pour Universal Health Services (UHS) ?
La dernière réduction pour Universal Health Services Inc a eu lieu le juillet 16, 2025 lorsque B of A Securities a changé leur objectif de prix de $215 à $185 pour Universal Health Services Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Universal Health Services (UHS) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Universal Health Services, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Universal Health Services a été déposée le août 26, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 26, 2026.
La note d'analyste pour Universal Health Services (UHS) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Universal Health Services (UHS) était un réitéré avec un objectif de prix de $227.00 à $227.00. Le prix actuel de Universal Health Services (UHS) est de $181.58, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.